openPR Logo
Press release

Pain Management Drugs Market Major players are Novartis AG, Eli Lilly & Company, Abbott Laboratories, Endo Health Solutions, Inc., Purdue Pharma L.P., Pfizer.

06-04-2019 07:04 PM CET | Health & Medicine

Press release from: Allied Market Research

Pain Management Drugs Market

Pain Management Drugs Market

Pain Management Drugs Market by Drug Class, Indications, and Geography: Global Opportunity Analysis and Industry Forecast, 2017-2023," the pain management drugs market accounted for $58,577 million in 2016, and is estimated to reach $77,131 million by 2023, registering a CAGR of 4% from 2017 to 2023. North America was the highest contributor to the pain management drugs market in 2016; however, Asia-Pacific is expected to witness the highest growth rate during the forecast period.

Download the Sample Report @ http://bit.ly/2KqdeVH

Pain is a complex medical condition, which not only affects the physical but also mental well-being of an individual. It is caused due to trauma or tissue damage, and its intensity varies from person to person. Based on the cause of pain, the treatment provided can be a simple or complex. Pain can be managed with the help of a variety of pharmacological and non-pharmacological therapies.

The availability of sophisticated treatment options and advancement in technology have increased life the expectancy rates globally, which has resulted in an increase in the geriatric population. As the elderly people are highly prone to suffer from pain owing to various reasons, rise in elderly population is a major factor contributing towards the growth of the global pain management market. As per the statistics provided by the UN Population Division, the total proportion of people above 60 years has increased from 12% in 1950 to 22% in 2011, and is projected to reach 32% by 2050. Moreover, increase in R&D investment and rise in outsourcing of pharmaceuticals are expected to fuel the market growth in developing regions such as Asia-Pacific and LAMEA. However, availability of alternative therapies and patent expiration of prescription drugs for treatment of pain hamper the growth of the market.

The opioids segment is was the largest contributor towards the market growth in 2016, due to high efficiency of opioids to relieve pain in major chronic conditions. Anesthetics is anticipated to possess the highest growth rate during the forecast period.

Postoperative pain and chronic back pain were among the largest contributors in 2016, owing to increase in the number of surgeries globally and rise in prevalence of chronic diseases that lead to back pain. Furthermore, cancer pain is expected to grow at the highest rate throughout the forecast period, owing to rise in prevalence of cancer worldwide.

Do Enquiry before purchasing Report@ http://bit.ly/2QJVfe0

North America is expected to generate the highest revenue during forecast period. However, Asia-Pacific is projected to grow at the highest rate during 2017-2023, due to increase in government initiatives to improve the healthcare infrastructure and improved regulatory framework.

KEY FINDINGS OF THE STUDY
• Cancer pain segment is projected to grow at the highest rate during the analysis period.
• Opioids segment generated the highest revenue, and is expected to continue its dominance during the forecast period.
• North America occupied almost half of the market, and is projected to continue its dominance in future.
• China is expected to grow at a CAGR of 6% over the forecast period.
• Postoperative pain was the largest contributor among the indication segment in 2016.

The key companies profiled in the report include Novartis AG, Eli Lilly & Company, Abbott Laboratories, Endo Health Solutions, Inc., Purdue Pharma L.P., Pfizer, Inc., F. Hoffmann La Roche Ltd., Merck & Co. Inc., Johnson & Johnson, and GlaxoSmithKline Plc.

Other prominent players in the value chain include Allergen Inc., Bayer AG, Bristol-Myers Squibb, Valeant Pharmaceuticals International Inc., Boehringer Ingelheim, Sorrento Therapeutics, WEX Pharmaceuticals, and Zynerba Pharmaceuticals.

Contact Us:-
David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
USA/Canada (Toll Free):
+1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com

About Us:-
Allied Market Research (AMR) is a full-service market research and business consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Pain Management Drugs Market Major players are Novartis AG, Eli Lilly & Company, Abbott Laboratories, Endo Health Solutions, Inc., Purdue Pharma L.P., Pfizer. here

News-ID: 1764621 • Views:

More Releases from Allied Market Research

France Cardiovascular Ultrasound Market Poised for Steady Growth Through 2030
France Cardiovascular Ultrasound Market Poised for Steady Growth Through 2030
The France cardiovascular ultrasound market is witnessing consistent expansion as cardiovascular diseases continue to pose a major public health challenge across the country. Cardiovascular ultrasound, also known as echocardiography, is a non-invasive imaging technique widely used to assess heart structure, blood flow, and cardiac function. Its growing adoption in early diagnosis, disease monitoring, and treatment planning has positioned it as an essential diagnostic tool in modern cardiology. According to market
Post-Traumatic Stress Disorder Treatment Market to Reach $26.1 Billion, Globally, by 2031 at 4.9% CAGR
Post-Traumatic Stress Disorder Treatment Market to Reach $26.1 Billion, Globally …
Allied Market Research published a report, titled, 'Post-Traumatic Stress Disorder Treatment Market by Treatment Type (Drugs, Pyschotherapy), By Age Group (Pediartic, Geriatric, Adult), By End User (Hospitals, Outpaitent Clinics, Mental Health Center, Others): Global Opportunity Analysis and Industry Forecast, 2021-2031.' According to the report, the global post-traumatic stress disorder treatment industry was estimated at $16.0 billion in 2021, and is anticipated to hit $26.1 billion by 2031, registering a CAGR
Food Minerals Market Growth Opportunities and Emerging Trends by Analysis of Key Vendors like Waitaki Bio, Cargill, SPI Pharma, Inc.
Food Minerals Market Growth Opportunities and Emerging Trends by Analysis of Key …
The global food minerals industry was valued at $1.6 billion in 2022, and is projected to reach $3 billion by 2032, registering with a CAGR of 6.3% from 2023 to 2032. The compromised quality of agricultural produce and food products is impacting human health negatively and is not able to fulfill the nutritional requirement of the body. It is difficult to consume the required number of food minerals & nutrients from
Global Contrast Media Injectors Market Is Expected to Reach $2.60 Billion by 2030
Global Contrast Media Injectors Market Is Expected to Reach $2.60 Billion by 203 …
According to the report published by Allied Market Research, the global Contrast Media Injectors Market was estimated at 1.40 billion in 2020 and is expected to hit $2.60 billion by 2030, registering a CAGR of 8.0% from 2021 to 2030. The report provides an in-depth analysis of the top investment pockets, top winning strategies, drivers & opportunities, market size & estimations, competitive scenario, and wavering market trends. ► Don't Miss Out

All 5 Releases


More Releases for Pain

Comprehensive Pain Management Services Expanded by Denver Pain Management Clinic
Image: https://www.globalnewslines.com/uploads/2025/01/1737464973.jpg Denver Pain Management Clinic announces expanded services for individuals suffering from chronic pain conditions throughout the Denver metropolitan area. The clinic, established in 2010, continues to strengthen its position as a leading provider of comprehensive pain management services in Colorado through its team of specialized Denver Pain Doctors. DENVER, CO - October 9, 2025 - Denver Pain Management Clinic [https://denverpainmanagementclinic.com/] announces expanded services for individuals suffering from chronic pain conditions
Enhanced Pain Relief Solutions at Advanced Pain Care
Image: https://www.globalnewslines.com/uploads/2025/03/3f3b6259bfdec02e5dcb7b9d0c838855.jpg Advanced Pain Care is helping people who suffer from chronic pain with sophisticated, evidence-based treatments. The clinic is particularly focused on non-surgical care that improves the quality of life. With a team of highly qualified pain experts, they work with patients who have back pain, joint pain, and nerve pain. Personalized Treatment for Every Pain Disorder Advanced Pain Care offers treatments depending on the cause of pain. Anyone experiencing arthritis, migraine,
Pain Finisher | Advanced Pain Relief Device
Pain Finisher is an instant pain relief device that is effective on all pains including back pain and knee pain. It is based on the TENS theory of pain management which is easy to use and safe. By using Pain Finisher, a modern drug-free and non-invasive pain-relieving treatment method, one can get rid of the common pain creams, gels, and risky treatment methods. So, have a pain-free life with easy-to-use pain relief
Neuropathic Pain Market: Innovative Therapies Reshaping Chronic Pain Management
In recent years, the global Neuropathic Pain Market has witnessed a dynamic shift, influenced by changing consumer preferences, technological advancements, and a growing emphasis on sustainability. The Research report on Neuropathic Pain Market presents a complete judgment of the market through strategic insights on future trends, growth factors, supplier landscape, demand landscape, Y-o-Y growth rate, CAGR, pricing analysis. It also provides and a lot of business matrices including
Visceral Pain Market Analysis 2024: Addressing Pain Management Challenges
The Business Research Company has released its latest global market reports, covering insights for 2024 and offering projections up to 2033. The Business Research Company presents an extensive market research report on the Visceral Pain Global Market Report 2024, furnishing businesses with a competitive edge through a detailed examination of the market structure, encompassing estimates for various segments and sub-segments. Furthermore, the report highlights on emerging trends, significant drivers, challenges, and opportunities,
Global Post-Operative Pain Management Market: Pain Relief Goes Worldwide
Introduction: The Global Post-Operative Pain Management Market is growing at a rapid pace. This market involves the management of pain after surgical procedures. The market has witnessed significant growth in recent years, owing to the increasing number of surgeries and the rising prevalence of chronic diseases. Pain management is an essential aspect of healthcare, as uncontrolled pain can lead to prolonged hospital stays, delayed recovery, and poor patient outcomes. In this article,